Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T55610 | Target Info | |||
Target Name | Hypoxia-inducible factor 1 alpha (HIF-1A) | ||||
Synonyms | bHLHe78; Transcription factor HIF-1; PASD8; PAS domain-containing protein 8; Member of PAS protein 1; MOP1; Hypoxia-inducible transcription factor (HIF)-1; Hypoxia-inducible factor 1-alpha; Hypoxia-inducible factor 1 A; Hypoxia inducible factor 1; HIF1-alpha; HIF1 alpha; HIF-1alpha; HIF-1-alpha; HIF-1 alpha; Class E basic helix-loop-helix protein 78; Basic-helix-loop-helix-PAS protein MOP1; ARNT-interacting protein; ARNT interacting protein | ||||
Target Type | Clinical trial Target | ||||
Gene Name | HIF1A | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acid anhydride hydrolases | [+] 2 Acid anhydride hydrolases | + | |||
Interacting Protein Name | RuvB-like 2 (RUVBL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ECP51; INO80J; REPTIN; RVB2; TIH2; TIP48; TIP49B | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Fluorescence Resonance Energy Transfer | [1] | |||
Interacting Target Name | DNA replication licensing factor MCM7 (MCM7) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P1.1-MCM3; Minichromosome maintenanceprotein 7; MCM2; CDC47 homolog; CDC47 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Reconstituted Complex | [3] | |||
Acyltransferases | [+] 5 Acyltransferases | + | |||
Interacting Target Name | Histone acetyltransferase p300 (EP300) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein propionyltransferase p300; p300 HAT; P300; Histone crotonyltransferase p300; Histone butyryltransferase p300; E1A-associated protein p300; E1Aassociated protein p300 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [4] | |||
3 | Reconstituted Complex | [5] | |||
4 | Yeast two hybrid | [6] | |||
Interacting Target Name | TNF receptor-associated factor 6 (TRAF6) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RNF85; RING-type E3 ubiquitin transferase TRAF6; RING finger protein 85; Interleukin-1 signal transducer; E3 ubiquitin-protein ligase TRAF6 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Co-localization | [8] | |||
3 | Reconstituted Complex | [7] | |||
Interacting Protein Name | E3 ubiquitin-protein ligase CHIP (STUB1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CHIP; HSPABP2; NY.CO.7; SCAR16; SDCCAG7; UBOX1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [10] | |||
3 | Reconstituted Complex | [9] | |||
Interacting Target Name | Histone acetyltransferase KAT2B (KAT2B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Spermidine acetyltransferase KAT2B; PCAF; P300/CBP-associated factor; P/CAF; Lysine acetyltransferase 2B; Histone acetyltransferase PCAF; Histone acetylase PCAF | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Biochemical Activity | [12] | |||
Interacting Target Name | Transcription intermediary factor 1-beta (TRIM28) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tripartite motif-containing protein 28; TIF1-beta; TIF1B; RNF96; RING-type E3 ubiquitin transferase TIF1-beta; RING finger protein 96; Nuclear corepressor KAP-1; KRIP-1; KRAB-interacting protein 1; KRAB-associated protein 1; KAP-1; KAP1; E3 SUMO-protein ligase TRIM28 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [13] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Receptor of activated protein C kinase 1 (RACK1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Small ribosomal subunit protein RACK1; Receptor of activated protein C kinase 1, N-terminally processed; Receptor for activated C kinase; Human lung cancer oncogene 7 protein; HLC-7; Guanine nucleotide-binding protein subunit beta-like protein 12.3; Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed; Guanine nucleotide-binding protein subunit beta-2-like 1; GNB2L1; Cell proliferation-inducing gene 21 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [7] | |||
3 | Reconstituted Complex | [14] | |||
Carbon-nitrogen hydrolases | [+] 5 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Reconstituted Complex | [15] | |||
Interacting Target Name | Histone deacetylase 2 (HDAC2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-localization | [16] | |||
2 | Reconstituted Complex | [17] | |||
Interacting Target Name | Histone deacetylase 4 (HDAC4) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | KIAA0288; HD4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [18] | |||
2 | Yeast two hybrid | [19] | |||
Interacting Target Name | NAD-dependent deacetylase sirtuin-1 (SIRT1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIR2-like protein 1; SIR2L1; Regulatory protein SIR2 homolog 1; NAD-dependent protein deacetylase sirtuin-1; hSIRT1; hSIR2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [20] | |||
2 | Reconstituted Complex | [11] | |||
Interacting Target Name | Histone deacetylase 3 (HDAC3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SMAP45; RPD3-2; RPD32; HD3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Reconstituted Complex | [15] | |||
Cell cycle related proteins | [+] 1 Cell cycle related proteins | + | |||
Interacting Target Name | Multiple tumor suppressor 1 (CDKN2A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumour suppressor gene p16; P16-INK4a; p16INK4A; P16-INK4; P16 gene; MTS-1; Cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Fluorescence Resonance Energy Transfer | [22] | |||
Cullins | [+] 1 Cullins | + | |||
Interacting Protein Name | Cullin-2 (CUL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [23] | |||
G-protein-coupled receptors | [+] 1 G-protein-coupled receptors | + | |||
Interacting Target Name | Extracellular calcium-sensing receptor (CASR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PCaR1; Parathyroid cell calcium-sensing receptor 1; Parathyroid Cell calcium-sensing receptor; Parathyroid cell calciumreceptor; Parathyroid calcium receptor; hCasR; GPRC2A; CaSR; CaR | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [24] | |||
2 | Reconstituted Complex | [25] | |||
Heat shock proteins | [+] 3 Heat shock proteins | + | |||
Interacting Protein Name | Heat shock 70 kDa protein 4 (HSPA4) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | APG.2; HEL.S.5a; HS24/P52; HSPH2; RY; hsp70; hsp70RY | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [26] | |||
3 | Reconstituted Complex | [27] | |||
Interacting Target Name | Heat shock protein 90 alpha (HSP90A) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Renal carcinoma antigen NY-REN-38; LPS-associated protein 2; Lipopolysaccharide-associated protein 2; LAP-2; HSPCA; HSPC1; HSP90A; HSP86; HSP 86; Heat shock protein HSP 90-alpha; Heat shock 86 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Reconstituted Complex | [29] | |||
Interacting Target Name | Heat shock protein 90 beta (HSP90B) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HSP84; HSP 84; Heat shock 84 kDa | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Reconstituted Complex | [29] | |||
Kinases | [+] 2 Kinases | + | |||
Interacting Target Name | Proto-oncogene c-Src (SRC) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase (pp60(src)); SRC1; Src tyrosine kinase; Proto-oncogene tyrosine-protein kinase Src; pp60c-src; Pp60(src); P60-Src; C-src TK; C-Src | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Co-localization | [32] | |||
Interacting Target Name | Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [33] | |||
Nuclear hormone receptors | [+] 1 Nuclear hormone receptors | + | |||
Interacting Target Name | Estrogen receptor (ESR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Oestrogen receptor alpha; Oestrogen receptor; Nuclear receptor subfamily 3 group A member 1; NR3A1; Estrogen receptor alpha; Estradiol receptor; ESR; ER-alpha; ERalpha; ER | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [34] | |||
2 | Affinity Capture-Western | [35] | |||
Oxidoreductases | [+] 5 Oxidoreductases | + | |||
Interacting Target Name | Quinone reductase 1 (NQO1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Qui reductase 1; QR1; Phylloquinone reductase; Phylloqui reductase; NMOR1; NAD(P)H:quinone oxidoreductase 1; NAD(P)H dehydrogenase [quinone] 1; Menadione reductase; DT-diaphorase 1; DT-diaphorase; DTD; DIA4; Azoreductase | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [36] | |||
3 | Reconstituted Complex | [36] | |||
Interacting Target Name | HIF-prolyl hydroxylase 2 (HPH-2) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SM-20; SM20; Prolyl hydroxylase domain-containing protein 2; Prolyl hydroxylase domaincontaining protein 2; PNAS-137; PNAS-118; PHD2; Hypoxia-inducible factor prolyl hydroxylase 2; Hypoxiainducible factor prolyl hydroxylase 2; HPH2; HIFprolyl hydroxylase 2; HIF-PH2; HIFPH2; Egl nine homolog 1; C1orf12 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [37] | |||
2 | Fluorescence Resonance Energy Transfer | [38] | |||
3 | Reconstituted Complex | [39] | |||
Interacting Protein Name | Egl nine homolog 3 (EGLN3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HIFP4H3; HIFPH3; PHD3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [40] | |||
2 | Reconstituted Complex | [41] | |||
3 | Yeast two hybrid | [42] | |||
Interacting Protein Name | Hypoxia-inducible factor 1-alpha inhibitor (HIF1AN) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | FIH1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [43] | |||
3 | Reconstituted Complex | [44] | |||
Interacting Target Name | HIF-prolyl hydroxylase 1 (HPH-1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Prolyl hydroxylase domain-containing protein 1; PHD1; Hypoxia-inducible factor prolyl hydroxylase 1; HPH-3; HIF-PH1; HIF-PH; Estrogen-induced tag6; Estrogen-induced tag 6; EIT-6; EIT6; Egl nine homolog 2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [45] | |||
2 | Reconstituted Complex | [41] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | JUN activation domain binding protein (COPS5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Signalosome subunit 5; SGN5; Jun activation domain-binding protein 1; JAB1; CSN5; COP9 signalosome complex subunit 5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [46] | |||
2 | Reconstituted Complex | [47] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [48] | |||
2 | Reconstituted Complex | [49] | |||
Transcription regulators | [+] 7 Transcription regulators | + | |||
Interacting Protein Name | Aryl hydrocarbon receptor nuclear translocator (ARNT) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | HIF.1.beta; HIF.1beta; HIF1.beta; HIF1B; HIF1BETA; TANGO; bHLHe2 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [50] | |||
2 | Affinity Capture-Western | [51] | |||
3 | Co-fractionation | [52] | |||
4 | Co-localization | [31] | |||
5 | Fluorescence Resonance Energy Transfer | [53] | |||
6 | Reconstituted Complex | [53] | |||
Interacting Target Name | Mothers against decapentaplegic homolog 3 (SMAD3) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TGF-beta response effector Smad3; Smad3; SMAD family member 3; SMAD 3; Mothers against DPP homolog 3; MMad3; MADH3; Mad3; MAD homolog 3; JV15-2; HSMAD3; HMAD-3 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [54] | |||
2 | Affinity Capture-Western | [55] | |||
3 | Co-localization | [55] | |||
4 | Reconstituted Complex | [55] | |||
5 | Yeast two hybrid | [54] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [56] | |||
2 | Co-crystal Structure | [57] | |||
3 | Fluorescence Resonance Energy Transfer | [58] | |||
4 | Reconstituted Complex | [59] | |||
5 | Yeast two hybrid | [59] | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Luminescence | [60] | |||
2 | Affinity Capture-Western | [61] | |||
3 | Co-localization | [62] | |||
4 | Reconstituted Complex | [61] | |||
Interacting Protein Name | CCAAT/enhancer-binding protein alpha (CEBPA) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | C/EBP.alpha; CEBP | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [63] | |||
2 | Co-localization | [64] | |||
3 | Reconstituted Complex | [63] | |||
Interacting Target Name | Proto-oncogene c-Myc (MYC) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcription factor p64; Proto-oncogene c-Myc; Myc proto-oncogene protein; C-myc oncogene; C-myc; Class E basic helix-loop-helix protein 39; bHLHe39 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [65] | |||
2 | Fluorescence Resonance Energy Transfer | [22] | |||
Interacting Target Name | Metastasis associated gene-1 (MTA1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Metastasis-associated protein MTA1; Metastasisassociated protein MTA1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [66] | |||
2 | Reconstituted Complex | [67] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [48] | |||
2 | Reconstituted Complex | [68] | |||
3 | Yeast two hybrid | [69] | |||
Other proteins | [+] 4 Other proteins | + | |||
Interacting Target Name | von Hippel-Lindau disease tumor suppressor (VHL) | Patented-recorded Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | pVHL; Protein G7 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [50] | |||
2 | Affinity Capture-Western | [70] | |||
3 | Protein-Fragment Complementation Assay | [71] | |||
4 | Protein-peptide | [72] | |||
5 | Reconstituted Complex | [73] | |||
Interacting Protein Name | Elongin-B (ELOB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ELOB; SIII | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [23] | |||
Interacting Protein Name | Elongin-C (ELOC) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIII; eloC | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [3] | |||
Interacting Protein Name | Four and a half LIM domains protein 2 (FHL2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AAG11; DRAL; FHL.2; SLIM.3; SLIM3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [74] | |||
2 | Reconstituted Complex | [74] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The TIP60 Complex Is a Conserved Coactivator of HIF1A. Cell Rep. 2016 Jun 28;16(1):37-47. | ||||
REF 2 | Negative regulation of hypoxic responses via induced Reptin methylation. Mol Cell. 2010 Jul 9;39(1):71-85. | ||||
REF 3 | MCM proteins are negative regulators of hypoxia-inducible factor 1. Mol Cell. 2011 Jun 10;42(5):700-12. | ||||
REF 4 | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell. 2013 Jun 6;153(6):1327-39. | ||||
REF 5 | Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex. J Am Chem Soc. 2013 Mar 20;135(11):4537-49. | ||||
REF 6 | Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell. 2004 Jul;6(1):33-43. | ||||
REF 7 | TRAF6 upregulates expression of HIF-1 and promotes tumor angiogenesis. Cancer Res. 2013 Aug 1;73(15):4950-9. | ||||
REF 8 | A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1 activation, tumorigenesis andmetastasis. Nat Cell Biol. 2017 Jan;19(1):38-51. | ||||
REF 9 | Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem. 2010 Feb 5;285(6):3651-63. | ||||
REF 10 | Functional regulation of hypoxia inducible factor-1 by SET9 lysine methyltransferase. Biochim Biophys Acta. 2015 May;1853(5):881-91. | ||||
REF 11 | Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell. 2010 Jun 25;38(6):864-78. | ||||
REF 12 | HIF1 protein stability is increased by acetylation at lysine 709. J Biol Chem. 2012 Oct 12;287(42):35496-505. | ||||
REF 13 | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. PLoS Pathog. 2013;9(11):e1003750. | ||||
REF 14 | Spermidine/spermine N(1)-acetyltransferase-1 binds to hypoxia-inducible factor-1alpha (HIF-1alpha) and RACK1 and promotes ubiquitination and degradation of HIF-1alpha. J Biol Chem. 2007 Nov 16;282(46):33358-66. | ||||
REF 15 | Regulation of the HIF-1alpha stability by histone deacetylases. Oncol Rep. 2007 Mar;17(3):647-51. | ||||
REF 16 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 17 | FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001 Oct 15;15(20):2675-86. | ||||
REF 18 | Transcriptional activation of hypoxia-inducible factor-1alpha by HDAC4 and HDAC5 involves differential recruitment of p300 and FIH-1. FEBS Lett. 2009 Jan 5;583(1):55-60. | ||||
REF 19 | Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity. J Biol Chem. 2004 Oct 1;279(40):41966-74. | ||||
REF 20 | Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1 protein under hypoxic conditions. PLoS One. 2012;7(3):e33433. | ||||
REF 21 | The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha ) and inhibits HIF-1-mediated transcription. J Biol Chem. 2001 Jul 27;276(30):28421-9. | ||||
REF 22 | OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc. Oncogene. 2017 Oct 19;36(42):5852-5860. | ||||
REF 23 | NEDD8 acts as a 'molecular switch' defining the functional selectivity of VHL. EMBO Rep. 2008 May;9(5):486-91. | ||||
REF 24 | Inhibitor of nuclear factor-kappaB alpha derepresses hypoxia-inducible factor-1 during moderate hypoxia by sequestering factor inhibiting hypoxia-inducible factor from hypoxia-inducible factor 1alpha. FEBS J. 2009 Jul;276(13):3470-80. | ||||
REF 25 | von Hippel-Lindau protein adjusts oxygen sensing of the FIH asparaginyl hydroxylase. Int J Biochem Cell Biol. 2011 May;43(5):795-804. | ||||
REF 26 | Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol. 2006 Mar;26(6):2019-28. | ||||
REF 27 | PI3K/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation. J Biol Chem. 2004 Apr 2;279(14):13506-13. | ||||
REF 28 | Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Cancer Res. 2006 Sep 1;66(17):8814-21. | ||||
REF 29 | MafG controls the hypoxic response of cells by accumulating HIF-1alpha in the nuclei. FEBS Lett. 2008 Jul 9;582(16):2357-64. | ||||
REF 30 | COMMD1 Promotes pVHL and O2-Independent Proteolysis of HIF-1alpha via HSP90/70. PLoS One. 2009 Oct 5;4(10):e7332. | ||||
REF 31 | Role of CBP in regulating HIF-1-mediated activation of transcription. J Cell Sci. 2005 Jan 15;118(Pt 2):301-11. | ||||
REF 32 | HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 2005 Apr 28;24(19):3110-20. | ||||
REF 33 | Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1 to promote cell-cycle progression. Proc Natl Acad Sci U S A. 2014 Aug 12;111(32):E3325-34. | ||||
REF 34 | Identification of proteins associated with ligand-activated estrogen receptor in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS. Proteomics. 2011 Jan;11(1):172-9. | ||||
REF 35 | Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. Mol Endocrinol. 2005 May;19(5):1191-9. | ||||
REF 36 | NQO1 inhibits proteasome-mediated degradation of HIF-1. Nat Commun. 2016 Dec 14;7:13593. | ||||
REF 37 | Myeloid translocation gene-16 co-repressor promotes degradation of hypoxia-inducible factor 1. PLoS One. 2015 May 14;10(5):e0123725. | ||||
REF 38 | Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling. J Cell Sci. 2012 Nov 1;125(Pt 21):5168-76. | ||||
REF 39 | A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):654-9. | ||||
REF 40 | HEXIM1 down-regulates hypoxia-inducible factor-1 protein stability. Biochem J. 2013 Dec 1;456(2):195-204. | ||||
REF 41 | The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Mol Cell Biol. 2007 May;27(10):3758-68. | ||||
REF 42 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 43 | A novel mode of action of YC-1 in HIF inhibition: stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}. Mol Cancer Ther. 2008 Dec;7(12):3729-38. | ||||
REF 44 | Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2). J Cell Sci. 2013 Jun 15;126(Pt 12):2629-40. | ||||
REF 45 | CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016 Jan 1;129(1):191-205. | ||||
REF 46 | HIF1-Induced by Lysophosphatidic Acid Is Stabilized via Interaction with MIF and CSN5. PLoS One. 2015 Sep 9;10(9):e0137513. | ||||
REF 47 | Distinct aerobic and hypoxic mechanisms of HIF-alpha regulation by CSN5. Genes Dev. 2004 Apr 1;18(7):739-44. | ||||
REF 48 | Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 2003 Apr 18;278(16):13595-8. | ||||
REF 49 | Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10305-9. | ||||
REF 50 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 51 | COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion. J Clin Invest. 2010 Jun;120(6):2119-30. | ||||
REF 52 | Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J Cell Sci. 1999 Apr;112 ( Pt 8):1203-12. | ||||
REF 53 | A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. J Am Chem Soc. 2013 Jul 17;135(28):10418-25. | ||||
REF 54 | A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads. J Mol Biol. 2004 Feb 6;336(1):9-24. | ||||
REF 55 | Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem. 2001 Oct 19;276(42):38527-35. | ||||
REF 56 | K63-polyubiquitinated HAUSP deubiquitinates HIF-1 and dictates H3K56 acetylation promoting hypoxia-induced tumour progression. Nat Commun. 2016 Dec 9;7:13644. | ||||
REF 57 | The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2. Biochem J. 2004 Aug 1;381(Pt 3):685-91. | ||||
REF 58 | Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300. J Biol Chem. 2010 Jan 22;285(4):2601-9. | ||||
REF 59 | Molecular mechanisms of transcription activation by HLF and HIF1alpha in response to hypoxia: their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 1999 Apr 1;18(7):1905-14. | ||||
REF 60 | Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem. 2002 Nov 15;277(46):43799-808. | ||||
REF 61 | The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression. EMBO J. 2006 Oct 18;25(20):4784-94. | ||||
REF 62 | HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol Cell. 2005 Mar 18;17(6):793-803. | ||||
REF 63 | CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Carcinogenesis. 2008 Feb;29(2):291-8. | ||||
REF 64 | Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells. J Biol Chem. 2011 Oct 21;286(42):36808-19. | ||||
REF 65 | HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004 May 5;23(9):1949-56. | ||||
REF 66 | Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1. EMBO J. 2006 Mar 22;25(6):1231-41. | ||||
REF 67 | Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha. Oncol Rep. 2006 Oct;16(4):929-35. | ||||
REF 68 | Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2. Cancer Res. 2007 Jan 15;67(2):450-4. | ||||
REF 69 | Nutlin-3, an Hdm2 antagonist, inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated inactivation of HIF-1alpha. Carcinogenesis. 2009 Oct;30(10):1768-75. | ||||
REF 70 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999 May 20;399(6733):271-5. | ||||
REF 71 | A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography. Nat Med. 2010 Aug;16(8):921-6. | ||||
REF 72 | pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science. 2016 Aug 26;353(6302):929-32. | ||||
REF 73 | Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2000 Jul;2(7):423-7. | ||||
REF 74 | Four-and-a-half LIM domain proteins inhibit transactivation by hypoxia-inducible factor 1. J Biol Chem. 2012 Feb 24;287(9):6139-49. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.